BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15623537)

  • 1. A novel protein derived from the MUC1 gene by alternative splicing and frameshifting.
    Levitin F; Baruch A; Weiss M; Stiegman K; Hartmann ML; Yoeli-Lerner M; Ziv R; Zrihan-Licht S; Shina S; Gat A; Lifschitz B; Simha M; Stadler Y; Cholostoy A; Gil B; Greaves D; Keydar I; Zaretsky J; Smorodinsky N; Wreschner DH
    J Biol Chem; 2005 Mar; 280(11):10655-63. PubMed ID: 15623537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MUC1 SEA module is a self-cleaving domain.
    Levitin F; Stern O; Weiss M; Gil-Henn C; Ziv R; Prokocimer Z; Smorodinsky NI; Rubinstein DB; Wreschner DH
    J Biol Chem; 2005 Sep; 280(39):33374-86. PubMed ID: 15987679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
    Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
    Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function.
    Baruch A; Hartmann M; Zrihan-Licht S; Greenstein S; Burstein M; Keydar I; Weiss M; Smorodinsky N; Wreschner DH
    Int J Cancer; 1997 May; 71(5):741-9. PubMed ID: 9180140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue.
    Zrihan-Licht S; Vos HL; Baruch A; Elroy-Stein O; Sagiv D; Keydar I; Hilkens J; Wreschner DH
    Eur J Biochem; 1994 Sep; 224(2):787-95. PubMed ID: 7925397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms.
    Zhang L; Vlad A; Milcarek C; Finn OJ
    Cancer Immunol Immunother; 2013 Mar; 62(3):423-35. PubMed ID: 22941036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1 splice variants in human ocular surface tissues: possible differences between dry eye patients and normal controls.
    Imbert Y; Darling DS; Jumblatt MM; Foulks GN; Couzin EG; Steele PS; Young WW
    Exp Eye Res; 2006 Sep; 83(3):493-501. PubMed ID: 16631167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a novel form of the breast cancer marker protein, MUC1, act as a receptor molecule that modulates signal transduction?
    Wreschner DH; Zrihan-Licht S; Baruch A; Sagiv D; Hartman ML; Smorodinsky N; Keydar I
    Adv Exp Med Biol; 1994; 353():17-26. PubMed ID: 7985536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Soluble expression of peptide containing MUC1/Y-specific epitope in Escherichia coli and preparation of the antibody].
    Zhang LX; Li CH; Sun LY; Wang M; Lu HJ
    Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):337-42. PubMed ID: 15969018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA.
    Chalick M; Jacobi O; Pichinuk E; Garbar C; Bensussan A; Meeker A; Ziv R; Zehavi T; Smorodinsky NI; Hilkens J; Hanisch FG; Rubinstein DB; Wreschner DH
    PLoS One; 2016; 11(10):e0165031. PubMed ID: 27768738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the human MUC1 oncoprotein.
    Duraisamy S; Kufe T; Ramasamy S; Kufe D
    Int J Oncol; 2007 Sep; 31(3):671-7. PubMed ID: 17671696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1.
    Kato M; Khan S; Gonzalez N; O'Neill BP; McDonald KJ; Cooper BJ; Angel NZ; Hart DN
    J Biol Chem; 2003 Sep; 278(36):34035-41. PubMed ID: 12824192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas.
    Denton G; Sekowski M; Spencer DI; Hughes OD; Murray A; Denley H; Tendler SJ; Price MR
    Br J Cancer; 1997; 76(5):614-21. PubMed ID: 9303360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MUC1 mucin gene by hamster tracheal surface epithelial cells in primary culture.
    Park H; Hyun SW; Kim KC
    Am J Respir Cell Mol Biol; 1996 Aug; 15(2):237-44. PubMed ID: 8703480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain.
    Panchamoorthy G; Rehan H; Kharbanda A; Ahmad R; Kufe D
    Hybridoma (Larchmt); 2011 Dec; 30(6):531-5. PubMed ID: 22149278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and expression of a synthetic mucin gene fragment in Escherichia coli.
    Dolby N; Dombrowski KE; Wright SE
    Protein Expr Purif; 1999 Feb; 15(1):146-54. PubMed ID: 10024481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of monoclonal antibody, PR81, recognizing the tandem repeat region of MUC1 mucin.
    Paknejad M; Rasaee MJ; Tehrani FK; Kashanian S; Mohagheghi MA; Omidfar K; Bazl MR
    Hybrid Hybridomics; 2003 Jun; 22(3):153-8. PubMed ID: 12954100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells.
    Julian J; Carson DD
    Biochem Biophys Res Commun; 2002 May; 293(4):1183-90. PubMed ID: 12054500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production and characterization of novel heavy-chain antibodies against the tandem repeat region of MUC1 mucin.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh A; Sarrami R; Nasiry H; Sadeghizadeh M
    Immunol Invest; 2005; 34(4):431-52. PubMed ID: 16302687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.
    Rubinstein DB; Karmely M; Ziv R; Benhar I; Leitner O; Baron S; Katz BZ; Wreschner DH
    Cancer Res; 2006 Dec; 66(23):11247-53. PubMed ID: 17145869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.